1,781
Views
33
CrossRef citations to date
0
Altmetric
Review

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management

ORCID Icon, , , , , & ORCID Icon show all
Pages 9363-9374 | Published online: 30 Sep 2020

References

  • El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. 2014;e461–6. doi:10.14694/EdBook_AM.2014.34.e46124857140
  • Blamey RW, Cataliotti L. EUSOMA accreditation of breast units. Eur J Cancer. 2006;42(10):1331–1337. doi:10.1016/j.ejca.2006.04.00316766180
  • National Cancer Institute. Defınition of tumor board review. Available from: http://www.cancer.gov/dictionary?cdrid=322893.
  • Dickhoff C, Dahele M. The multidisciplinary lung cancer team meeting: increasing evidence that it should be considered a medical intervention in its own right. J Thorac Dis. 2019;11(3):311–314. doi:10.21037/jtd.2019.01.14
  • Vlasto Milligan. Further reports on cases exhibited before the section at previous meetings, session 1921–1922. Proc R Soc Med. 1922;15:i.1–vii.1.
  • O’Brien JC. History of tumor site conferences at Baylor University Medical Center. Proc (Bayl Univ Med Cent). 2006;19(2):130–131. doi:10.1080/08998280.2006.1192814516609739
  • Munro AJ, Swartzman S. What is a virtual multidisciplinary team (vMDT)? Br J Cancer. 2013;108(12):2433–2441. doi:10.1038/bjc.2013.23123756866
  • Hermes-Moll K, Dengler R, Riese C, Baumann W. Tumor boards from the perspective of ambulant oncological care. Oncol Res Treat. 2016;39:377–383. doi:10.1159/00044631127260517
  • Horlait M, Baes S, Dhaene S, Van Belle S, Leys M. How multidisciplinary are multidisciplinary team meetings in cancer care? An observational study in oncology departments in Flanders, Belgium. J Multidiscip Healthc. 2019;12:159–167. doi:10.2147/JMDH.S19666030863082
  • Takeda T, Takeda S, Uryu K, et al. Multidisciplinary lung cancer tumor board connecting eight general hospitals in Japan via a high-security communication line. JCO Clin Cancer Inform. 2019;3:1–7. doi:10.1200/CCI.18.00115
  • El Saghir NS, Charara RN, Kreidieh FY, et al. Global practice and efficiency of multidisciplinary tumor boards: results of an American Society of Clinical Oncology International Survey. J Glob Oncol. 2015;1(2):57–64. doi:10.1200/JGO.2015.00015828804774
  • El Saghir NS, El-Asmar N, Hajj C. Survey of utilization of multidisciplinary management tumor boards in Arab countries. Breast. 2011;20(Suppl 2):70–74. doi:10.1016/j.breast.2011.01.011
  • Lumenta DB, Sendlhofer G, Pregartner G, et al. Quality of teamwork in multidisciplinary cancer team meetings: a feasibility study. PLoS One. 2019;14(2):e0212556. doi:10.1371/journal.pone.021255630768645
  • Choy E, Chiu A, Butow P, Young J, Spillane A. A pilot study to evaluate the impact of involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan. Breast. 2007;16:178–189. doi:10.1016/j.breast.2006.10.00217158048
  • Butow P, Harrison J, Choy E, Young J, Spillane A, Evans A. Health professional and consumer views on involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan. Cancer. 2007;110:1937–1944. doi:10.1002/cncr.2300717823912
  • Siddique O, Yoo ER, Perumpail RB, et al. The importance of a multidisciplinary approach to hepatocellular carcinoma. J Multidiscip Healthc. 2017;Volume 10(10):95–100. doi:10.2147/JMDH.S128629
  • Rainone F. Treating adult cancer pain in primary care. J Am Board Fam Pract. 2004;17(Suppl 1):S48–56. doi:10.3122/jabfm.17.suppl_1.S4815575030
  • Johnston MJ, King D, Arora S, et al. Smartphones let surgeons know WhatsApp: an analysis of communication in emergency surgical teams. Am J Surg. 2015;209(1):45–51. doi:10.1016/j.amjsurg.2014.08.03025454952
  • Mascia D, Rinninella E, Pennacchio NW, Cerrito L, Gasbarrini A. It’s how we communicate! Exploring face-to-face versus electronic communication networks in multidisciplinary teams. Health Care Manage Rev. 2019. doi:10.1097/HMR.0000000000000246
  • Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–431. doi:10.1016/j.ijsu.2010.02.00720171303
  • Croke JM, El-Sayed S. Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature. Curr Oncol. 2012;19(4):e232–8. doi:10.3747/co.19.94422876151
  • Kabat GC, Matthews CE, Kamensky V, Hollenbeck AR, Rohan TE. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. Am J Clin Nutr. 2015;101(3):558–569. doi:10.3945/ajcn.114.09485425733641
  • Jury RP, Nadeau L, Wasvary H, Levine R, Robertson J. Implementing a multidisciplinary open-access clinic at a private practice-based community hospital. J Oncol Pract. 2010;6(6):e38–41. doi:10.1200/JOP.2010.00002921358950
  • Gross GE. The role of the tumor board in a community hospital. CA Cancer J Clin. 1987;37(2):88–92. doi:10.3322/canjclin.37.2.883102006
  • Riquet M, Mordant P, Henni M, et al. Should all cases of lung cancer be presented at tumor board conferences? Thorac Surg Clin. 2013;23(2):123–128. doi:10.1016/j.thorsurg.2013.01.00323566964
  • Hollunder S, Herrlinger U, Zipfel M, et al. Cross-sectional increase of adherence to multidisciplinary tumor board decisions. BMC Cancer. 2018;18(1):936. doi:10.1186/s12885-018-4841-430268109
  • Shah BA, Qureshi MM, Jalisi S, et al. Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines. Pract Radiat Oncol. 2016;6(4):248–254. doi:10.1016/j.prro.2015.11.00626777060
  • Brauer DG, Strand MS, Sanford DE, et al. Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study. HPB. 2017;19(2):133–139. doi:10.1016/j.hpb.2016.11.00227916436
  • Ioannidis A, Konstantinidis M, Apostolakis S, Koutserimpas C, Machairas N, Konstantinidis KM. Impact of multidisciplinary tumor boards on patients with rectal cancer. Mol Clin Oncol. 2018;9(2):135–137. doi:10.3892/mco.2018.165830101009
  • Basse C, Thureau S, Bota S, et al. Multidisciplinary tumor board decision making for postoperative radiotherapy in thymic epithelial tumors: insights from the RYTHMIC prospective cohort. J Thorac Oncol. 2017;12(11):1715–1722. doi:10.1016/j.jtho.2017.07.02328774861
  • Somashekhar SP, Sepúlveda MJ, Puglielli S, et al. Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol. 2018;29(2):418–423. doi:10.1093/annonc/mdx78129324970
  • Lamb BW, Green JS, Benn J, Brown KF, Vincent CA, Sevdalis N. Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1,421 patients. J Am Coll Surg. 2013;217(3):412–420. doi:10.1016/j.jamcollsurg.2013.04.03523891067
  • Shah S, Arora S, Atkin G, et al. Decision-making in colorectal cancer tumor board meetings: results of a prospective observational assessment. Surg Endosc. 2014;28(10):2783–2788. doi:10.1007/s00464-014-3545-324879132
  • Jalil R, Akhter W, Lamb BW, et al. Validation of team performance assessment of multidisciplinary tumor boards. J Urol. 2014;192(3):891–898. doi:10.1016/j.juro.2014.03.00224631109
  • Serper M, Taddei TH, Mehta R, et al.; VOCAL Study Group. Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality. Gastroenterology. 2017;152(8):1954–1964. doi:10.1053/j.gastro.2017.02.040.28283421
  • Agarwal PD, Phillips P, Hillman L, et al. Multidisciplinary management of hepatocellular carcinoma improves access to therapy and patient survival. J Clin Gastroenterol. 2017;51(9):845–849. doi:10.1097/MCG.000000000000082528877082
  • Liu JC, Kaplon A, Blackman E, Miyamoto C, Savior D, Ragin C. The impact of the multidisciplinary tumor board on head and neck cancer outcomes. Laryngoscope. 2019;130:946–950.31095740
  • Blay JY, Soibinet P, Penel N, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28(11):2852–2859. doi:10.1093/annonc/mdx48429117335
  • Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344:e2718. doi:10.1136/bmj.e271822539013
  • Newman EA, Guest AB, Helvie MA, et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. 2006;107(10):2346–2351. doi:10.1002/cncr.2226616998942
  • Lee B, Kim K, Choi JY, et al. Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: a prospective study. Medicine. 2017;96(48):e8089. doi:10.1097/MD.000000000000808929310324
  • Wheless SA, McKinney KA, Zanation AM. A prospective study of the clinical impact of a multidisciplinary head and neck tumor board. Otolaryngol Head Neck Surg. 2010;143:650–654. doi:10.1016/j.otohns.2010.07.02020974334
  • AlFarhan HA, Algwaiz GF, Alzahrani HA, et al. Impact of GI tumor board on patient management and adherence to guidelines. J Glob Oncol. 2018;4:1–8. doi:10.1200/JGO.17.00164
  • Lowes M, Kleiss M, Lueck R, et al. The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer. Int J Colorectal Dis. 2017;32(10):1463–1469. doi:10.1007/s00384-017-2871-z28779354
  • Pawlik TM, Laheru D, Hruban RH, et al.; Johns Hopkins Multidisciplinary Pancreas Clinic Team. Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol. 2008;15(8):2081–2088. doi:10.1245/s10434-008-9929-7.18461404
  • Deressa BT, Cihoric N, Tefesse E, Assefa M, Zemenfes D. Multidisciplinary Cancer Management of Colorectal Cancer in Tikur Anbessa Specialized Hospital, Ethiopia. J Glob Oncol. 2019;5:1–7. doi:10.1200/JGO.19.00014
  • Solomon D, DeNicola N, Feferman Y, et al. Assessing the Implementation of American College of Surgeons Quality Indicators for Pancreatic Cancer Across an Integrated Health System. J Oncol Pract. 2019;15(8):e739–e745. doi:10.1200/JOP.18.0058731260384
  • Wotman M, Ghaly M, Massaro L, et al. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: an institutional experience. Am J Otolaryngol. 2019;40(5):684–690. doi:10.1016/j.amjoto.2019.06.00331229365
  • Herlemann A, Washington SL, Cooperberg MR. Health care delivery for metastatic hormone-sensitive prostate cancer across the globe. Eur Urol Focus. 2019;5(2):155–158. doi:10.1016/j.euf.2018.12.00330587443
  • Fazio N, Ungaro A, Spada F, et al. The role of multimodal treatment in patients with advanced lung neuroendocrine tumors. J Thorac Dis. 2017;9(Suppl 15):S1501–S1510. doi:10.21037/jtd.2017.06.1429201453
  • Rubins J, Unger M, Colice GL; American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007;132(3):355S–367S. doi:10.1378/chest.07-139017873180
  • Gambazzi F, Frey LD, Bruehlmeier M, et al. Image analysis in posttreatment non-small cell lung cancer surveillance: specialists’ interpretations reviewed by the thoracic multidisciplinary tumor board. Multidiscip Respir Med. 2019;14:34. doi:10.1186/s40248-019-0198-z31827794
  • Kuroki L, Stuckey A, Hirway P, et al. Addressing clinical trials: can the multidisciplinary tumor board improve participation? A study from an academic women’s cancer program. Gynecol Oncol. 2010;116(3):295–300. doi:10.1016/j.ygyno.2009.12.00520042225
  • van de Velde CJ, Boelens PG, Borras JM, et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer. 2014;50(1):1–e1. doi:10.1016/j.ejca.2013.06.04824183379
  • Mañós M, Giralt J, Rueda A, et al. Multidisciplinary management of head and neck cancer: first expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1). Oral Oncol. 2017;70:58–64. doi:10.1016/j.oraloncology.2017.04.00428427761
  • Rueda A, Giralt J, Mañós M, et al. Multidisciplinary management of head and neck cancer: first expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2). Oral Oncol. 2017;70:65–72. doi:10.1016/j.oraloncology.2017.04.00528427762
  • Bajetta E, Celio L, Platania M, et al. Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann Surg Oncol. 2009;16(11):2985–2993. doi:10.1245/s10434-009-0615-119609619
  • Taddei TH. A multidisciplinary approach: group dynamics. J Clin Gastroenterol. 2013;47:S27–9. doi:10.1097/MCG.0b013e31829331de23632364
  • Asghar AH, Abbasi AN, Jamal A, Haider G, Rizvi S. City tumour board Karachi: an innovative step in multidisciplinary consensus meeting and its two years audit. J Pak Med Assoc. 2013;63(12):1534–1535.24397101
  • Sandrucci S, Naredi P, Bonvalot S. Centers of excellence or excellence networks: the surgical challenge and quality issues in rare cancers. Eur J Surg Oncol. 2019;45(1):19–21. doi:10.1016/j.ejso.2017.12.01229395437
  • Bui NQ, Wang DS, Hiniker SM. Contemporary management of metastatic soft tissue sarcoma. Curr Probl Cancer. 2019;43(4):289–299. doi:10.1016/j.currproblcancer.2019.06.00531248634
  • Hahlweg P, Didi S, Kriston L, Härter M, Nestoriuc Y, Scholl I. Process quality of decision-making in multidisciplinary cancer team meetings: a structured observational study. BMC Cancer. 2017;17(1):772. doi:10.1186/s12885-017-3768-529149872
  • Ung KA, Campbell BA, Duplan D, Ball D, David S. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer. Asia Pac J Clin Oncol. 2016;12(2):e298–304. doi:10.1111/ajco.1219224674013
  • Zekri J, Dreosti LM, Ghosn M, et al. Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvement. J Multidiscip Healthc. 2015;27(8):335–344. doi:10.2147/JMDH.S85538
  • Fayet Y, Coindre JM, Dalban C, et al. Geographical accessibility of the referral networks in France. Intermediate results from the IGéAS research program. Int J Environ Res Public Health. 2018;15(10):2204. doi:10.3390/ijerph15102204
  • Walsh S, de Jong EEC, van Timmeren JE, et al. Decision support systems in oncology. JCO Clin Cancer Inform. 2019;3:1–9. doi:10.1200/CCI.18.00001
  • Krupinski EA, Comas M; Gallego LG on behalf of the GISMAR Group. A new software platform to improve multidisciplinary tumor board workflows and user satisfaction: a pilot study. J Pathol Inform. 2018;9:26. doi:10.4103/jpi.jpi_16_1830167341
  • Gallagher SA, Smith AB, Matthews JE, et al. Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database–UNC GOLD. Urol Oncol. 2014;32(1):32–e1. doi:10.1016/j.urolonc.2012.11.019